The synthetic design
. The importance of one or both of these reactions in hypertensive disease has been greatly clarified in recent years by the development of specific, orally active inhibitors of ACE. Captopril (5) (6) (7) and enalapril (8-10) are potent, orally active ACE inhibitors, which have been shown to be effective for the treat ment of hypertension in humans (11) (12) (13) (14) . Since the discovery of these drugs, many analogues have been prepared (15) (16) (17) (18) , and their structure-activity relationships have been studied. Petrillo and Ondetti (19) proposed a model of the ACE active site to which peptide substrates and inhibitors bind. However, the spatial orientation of the enzyme binding sites and the inhibitor conformation required for binding have not been clarified. One way to approach the problem is to restrict the possible conformations of ACE inhibitors by synthesizing rigid molecules. We have already reported a new ACE inhibitor, delapril HCI (CV-3317, Compound 1 a in Fig.  1 ), which is more potent and has longer lasting action than captopril (20, 21) . In the present paper, the design and the structure activity relationships of synthetic (R)-3 amino-4-oxo-2,3,4,5-tetrahydro-1,5,-benzo thiazepine derivatives are described.
Materials and Methods

Conformational analysis:
The energy minimized conformations of delapril HCI (CV 3317), enalapril and (R)-3-amino-4-oxo 2,3,4,5 tetrahydro -1,5 benzothiazepine 5 acetic acid were generated by computer calculation using programs M M2 and M N DO.
2. Inhibition of pressor response to angio tensin I (A-I) in rats: Male Sprague-Dawley rats (SD:Jcl), weighing 300-400 g, were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and were prepared with an aortic catheter and a caval catheter inserted via the right femoral artery and vein, respec tively. Both catheters were passed subcu taneously to the neck and were exposed there. After surgery, the animals were placed into plastic cages and allowed freedom of movement; tap water was provided ad libitum, but food was withheld. Experiments were started on the next morning after surgery. The aortic cannula was connected to a pressure transducer, and the mean blood pressure was recorded on a polygraph. The pressor responses to A-I (300 ng/kg) and A-II (100 ng/kg) were measured after injection of each compound into the femoral vein. The response to each compound was measured twice, and the average response to each drug was used as the control in all calculations. After blood pressure had returned to the pretreatment level, ACE inhibitors were administered p.o. or i.v. to the rats. Thereafter, the A-I and A-II chal lenges were repeated at set times. Inhibition by the test compounds of the pressor response to A-I was determined. The A-II challenge was used to correct the percent inhibition value, based on the change of vascular responsiveness during the course of the experiment. 3. Inhibition of ACE in vitro: Angiotensin converting enzyme (ACE) was prepared from the lungs of albino male rabbits as previously described (20) . Lung homogenates were prepared by a slight modification of the method described by Wallace et al. (22) in that the tissue was homogenized in 9 volumes of 100 mM borate HCI buffer containing 300 mM NaCI (pH 8.3), and then the homoge nates were centrifuged for 25 min. The filtered supernatant was used as the source of crude ACE. Enzyme activity was determined by a slight modification of the spectro photometric method described by Cushman and Cheung (3) in which the conversion of the synthetic substrate hippuryl-L-histidyl-L leucine (H H L) to hippuric acid was measured. The assay mixture contained 5 mM HHL, 300 mM NaCI, 100 mM borate-HCI buffer, test compound (10-8 M) and the crude ACE in a total volume of 250 Pl. The mixture was incubated at 37°C for 60 min. The reaction was terminated by adding 1 N HCI (150 id), and the hippuric acid formed was extracted with 2 volumes of ethyl acetate and its con centration determined from its absorbance at 228 nm. 4. Drugs: Angiotensin I, angiotensin II and hippuryl-L-histidyl-L-leucine were obtained from the Protein Research Foundation; hip puric acid was from Sigma; heparin was from Shimizu Pharmaceutical Co; and pentobarbi tal-Na (Somnopentyl) was from Pitman Moore. The test compounds, (R) -3-amino-4 oxo-2,3,4,5-tetrahydro-1,5-benzothiazepine 5-acetic acid derivatives, and CV-3317 COOH were synthesized as described in previous reports (23, 24) . amino-4-oxo-2,3,4,5-tetra hydro-1,5-benzo thiazepine-5-acetic acid according to the Dreiding model. Examination of these con formations indicates that they all have the same spatial orientation. The functional groups such as carboxy, amide, amino and hydrophobic moieties are located in the same positions in these 3 compounds.
2. Structure-activity relationship: The ACE inhibitory activities of compounds 3, 4, 5, 6 and 7 are given in Table 1 . Intravenous administration of these compounds at 0.3 mg/kg potently inhibited the A-I induced pressor response, but the duration of activity varied (Fig. 3 ). Compound 7, a piperidyl derivative, displayed longer-lasting activity than the corresponding phenyl derivative (compound 3).
As shown in Fig. 4 , in addition to com pound 7, other piperidyl derivatives (com pound 8, 9a, 10 and 11) had potent and long lasting activity in vivo, when administered intravenously at 0.3 mg/kg. The duration of activity after i.v. administration closely cor related with the length of the carbon chain in the 1-carboxy-o-(4-piperidyl)alkyl group, and out of the series of benzothiazepine derivatives examined, maximum duration was observed with the 1-carboxy-5-(4-piperidyl) pentylamino derivative (compound 9a, CV 5975). 
ACE inhibitory activity of CV-5975 and its stereoisomers:
CV-5975 (compound 9a) and its 3 stereoisomers (compounds 9b, 9c and 9d) were evaluated for their inhibitory activity on rabbit lung ACE and A-I pressor response in rats. As shown in Table 2 , the 3 isomers of CV-5975 (compound 9a) showed only very weak inhibition in both assays.
4. Oral absorption of CV-5975 and its ester form: CV-5975 (compound 9a) and its ester form (compound 9e) were adminis tered orally to rats at 3 mg/kg and their inhibitory activities were evaluated. CV-5975 (compound 9a) exhibited potent ACE in hibitory activity, but its ester form did not (Table 3) . Table 2 . Inhibitory effects of stereoisomers of CV-5975 on rabbit lung ACE and angiotensin I (A-I) induced pressor response in rats Table 3 , Inhibitory effects of CV-5975 (9a) and its ester (9e) on angiotensin I (A-I) induced pressor response in rats
Discussion
Conformational examination using a Dreid ing model indicated that CV-3317-COOH (compound 1 b in Fig. 1 ) is expected to be stable, because it has a low level of non bonded interactions. Although the tricyclic fused compound (compound 2) clearly cor responds to CV-3317-COOH, the structure was rather complicated to synthesize. Car boxyl, amido, amino and hydrophobic moie ties are located in the same positions in the computer-drawn structure of alanylproline, alanyl indanyl glycine and (R)-3-amino-4 oxo-2,3,4,5-tetrahydro-l ,5-benzothiazepine 5-acetic acid. The test compounds were designed to incorporate conformational res triction in rigid skeletons. Compounds 3, 4, 5, 6 and 7 were highly active against rabbit lung ACE, and their potencies were comparable to that of CV 3317-COOH (compound 1b, Table 1 ) (23) . Based on the finding that compound 3 and its derivatives showed potent ACE inhibitory activity, we speculated that the functional groups on compound 3 such as carboxyl, amido, amino and hydrophobic moieties might be located in favorable positions for binding to active sites in ACE. The structure activity relationships of these compounds provided some information on the structural requirements of the substituent R for prolong ing the in vivo ACE-inhibitory activity. A piperidylpentylamino derivative induced the longest lasting inhibition of ACE in the series of benzoxazepine derivatives examined. CV-5975 has 3 stereoisomers, and these 3 isomers showed only weak inhibition for ACE. The importance of chiral requirements for activity has been established in several studies on ACE inhibitors (5, 8, 19, (23) (24) (25) (26) .
It is known that enalapril and delapril HCI, which are monoacids, are orally well absorbed pro-drugs (9, 20) and that the corresponding diacids produced after dees terification in vivo are the active compounds. CV-5975 exhibited potent ACE inhibitory activity, but its ester form did not. In contrast to enalapril and delapril HCI, CV-5975 itself has two free carboxy groups and it is absorbed in an active form.
Maximum duration of activity was observed with the piperidylpentylamino derivatives out of the series of benzoxazepine derivatives examined (24) . The distance (9-10 A from a Dreiding model) between the two nitrogen atoms of the piperidylpentylamino moiety is almost equal to that of the 6 or 7 alkylene chain in the aminooctyl moiety which had the longest duration of activity among the series of aminoalkylamino derivatives (25) . This finding indicates that a basic amino group is essential for longlasting inhibitory activity in vivo. Although the role of the nitrogen atom in prolonging the duration of action is not yet clear, it might be related to the existence of an additional binding site on ACE and/or it may confer increased affinity to ACE (27) .
